Aroa Biosurgery Materials

$0.925 0.030 (3.35%)

High $0.93	Low $0.90	Trades 28	Turnover $33,271	Volume 36,561
30 June 2023 at 4:10pm

Register to track ARX and receive email alerts.

Market Cap (19-Sep) $228,857,328 (538th)	Close (30-Jun) $0.93 0 (0%)	Volume (30-Jun) 36,561	Shortsold (26-May) 120,477 (0.03%) (516th)
52w High $0.80	52w Low $0.460	P/E 80.00	EPS 0.01

	Subject
	ARX ARX Ann: New real-world data shows Endoform improves wound closure
	1 (current) 2 3
	ARX ARX Ann: Application for quotation of securities - ARX
	ARX ARX Ann: Section 708A Cleansing Statement
	ARX ARX Ann: Settlement of Placement, Offer Booklet & Opening of SPP
	ARX ARX Ann: Myriad Matrix Validated for PS Disease Tissue Reconstruction
	ARX ARX Ann: Special Instructions for Access to SPP Documents
	ARX ARX Ann: Investor Webinar
	ARX ARX Ann: Proposed issue of securities - ARX
	ARX ARX Ann: Proposed issue of securities - ARX
	ARX ARX Ann: Investor Presentation
	ARX ARX Ann: Aroa Completes $47m Placement and Launches $5m SPP
	ARX ARX Ann: Trading Halt
	ARX ARX Ann: Results of Annual General Meeting
	ARX ARX Ann: CEO Presentation - AGM
	ARX ARX Ann: Chairman's Address - AGM
	ARX ARX Ann: Release of Shares from Voluntary Escrow
	ARX ARX Ann: June Quarterly Report and Appendix 4C
	ARX ARX Ann: Notification of cessation of securities - ARX
	ARX ARX Ann: Notification regarding unquoted securities - ARX
	ARX ARX Ann: Appendix 3G
	ARX ARX Ann: Investor Day Presentation
	ARX ARX Ann: Investor Day - 5 July
	ARX ARX Ann: Notice of Annual General Meeting/Proxy Form
	ARX ARX Ann: Appendix 4G and Corporate Governance Statement
	ARX ARX Ann: Annual Report to Shareholders
	ARX ARX Ann: Change of Director's Interest Notice - PM
	ARX ARX Ann: Application for quotation of securities - ARX
	ARX ARX Ann: Application for quotation of securities - ARX
	ARX ARX Ann: Section 708A Cleansing Statement
	ARX ARX Ann: FY21 Full Year Results Presentation
	ARX ARX Ann: Preliminary Final Report
	ARX ARX Ann: Notice of AGM Date and Director Nomination Closing Date
	ARX ARX Ann: Aroa Biosurgery Full Year Results Webinar
	ARX ARX Ann: Appendix 3G
	ARX ARX Ann: Quarterly Results Webinar
	ARX ARX Ann: March Quarterly Report and Appendix 4C
	ARX ARX Ann: Change of Registered Office
	ARX ARX Ann: Aroa secures FDA clearance for new product
	ARX ARX Ann: Aroa to present at NWR Virtual Investor Conference
	ARX ARX Ann: S&P DJI Announces March 2021 Quarterly Rebalance
	ARX ARX Ann: Change of Director's Interest Notice - JD
	ARX ARX Ann: Pilot study indicates benefits of Myriad in surgical reconst
	ARX ARX Ann: Aroa to further expand dedicated US sales team
	ARX ARX Ann: Change in substantial holding
	ARX ARX Ann: December Quarterly Report and Appendix 4C
	ARX ARX Ann: Aroa Biosurgery December 2020 Quarterly Webinar
	ARX ARX Ann: Release of Shares from Voluntary Escrow
	ARX ARX Ann: New Study Shows Myriad Efficacy in Exposed Vital Structures
	ARX ARX Ann: Change of Director's Interest Notice - JD
	ARX ARX Ann: Section 708A Cleansing Statement and Appendix 2A

Register to track ARX and receive email alerts.

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.70	337,379	-0.01 (0.71%)
12-Sep	$0.70	341,654	0.00 (0.00%)
11-Sep	$0.70	241,500	+0.05 (7.69%)
05-Sep	$0.65	382,350	0.00 (0.00%)
04-Sep	$0.65	100,052	0.00 (0.00%)
03-Sep	$0.65	154,180	0.00 (0.00%)
29-Aug	$0.65	285,007	0.00 (0.00%)
28-Aug	$0.65	144,513	0.00 (0.00%)
22-Aug	$0.65	73,324	+0.01 (1.56%)
21-Aug	$0.64	298,235	+0.02 (2.40%)
15-Aug	$0.63	311,735	-0.01 (0.79%)
14-Aug	$0.63	82,851	+0.02 (3.28%)
07-Aug	$0.61	144,258	-0.02 (3.17%)
31-Jul	$0.63	68,638	-0.02 (2.33%)
30-Jul	$0.65	522,136	+0.03 (4.88%)
5 up, 4 down, and 6 flat days